Du Tan, Wu Zonglong, Wu Yaqian, Liu Yunchong, Song Yimeng, Ma Lulin
Department of Urology, Peking University Third Hospital, Beijing 100191, China.
Biomedicines. 2023 Jul 24;11(7):2077. doi: 10.3390/biomedicines11072077.
In many solid tumors, CD44 has been identified as a cancer stem cell marker as well as an important molecular in cancer progression and metastasis, making it attractive for potential therapeutic applications. However, our knowledge of the biological function and mechanism of CD44 in clear cell renal cell carcinoma (ccRCC) is limited.
In this study, the expression, prognostic values and functional enrichment analysis of CD44 in ccRCC were analyzed using public databases. Quantitative real-time PCR (qRT-PCR), Western blotting, and immunohistochemical (IHC) assays were taken to detect CD44 expression in ccRCC tissues. The effects of CD44 on the proliferation, migration and invasion of ccRCC cells were investigated by gain-of-function and loss-of-function experiments. Subcutaneous models further confirmed the role of CD44 in tumor growth. The relationship between CD44, HAS1 and MMP9 was investigated to uncover the regulatory mechanism of CD44 in ccRCC.
CD44 was significantly upregulated in ccRCC and associated with poor overall survival (OS). Based on the functional enrichment analysis and PPI network, we found that CD44 had associations with ECM interaction and focal adhesion pathway. Clinical ccRCC sample validation revealed that CD44 mRNA and protein expression were significantly increased in ccRCC tissues, and strong CD44 staining was observed in four metastatic ccRCC cases. In vitro experiments showed that CD44 overexpression promoted cell proliferation, migration and invasion. In vivo experiments also demonstrated that CD44 overexpression accelerated tumor formation in mice. Finally, we found that CD44 regulates the expression of HAS1 in ccRCC, which is essential for the secretion of MMP9 and cell migratory ability.
The upregulation of CD44 mRNA and protein expressions in ccRCC is indicative of unfavorable clinical prognoses. The CD44/HAS1/MMP9 axis is believed to exert a significant influence on the regulation of ECM degradation and ccRCC metastasis.
在许多实体瘤中,CD44已被鉴定为癌症干细胞标志物以及癌症进展和转移中的重要分子,使其在潜在治疗应用中具有吸引力。然而,我们对CD44在透明细胞肾细胞癌(ccRCC)中的生物学功能和机制的了解有限。
在本研究中,使用公共数据库分析了ccRCC中CD44的表达、预后价值和功能富集分析。采用定量实时PCR(qRT-PCR)、蛋白质印迹和免疫组织化学(IHC)检测ccRCC组织中CD44的表达。通过功能获得和功能丧失实验研究CD44对ccRCC细胞增殖、迁移和侵袭的影响。皮下模型进一步证实了CD44在肿瘤生长中的作用。研究了CD44、HAS1和MMP9之间的关系,以揭示CD44在ccRCC中的调节机制。
CD44在ccRCC中显著上调,并与总体生存期(OS)较差相关。基于功能富集分析和蛋白质-蛋白质相互作用(PPI)网络,我们发现CD44与细胞外基质(ECM)相互作用和粘着斑途径有关。临床ccRCC样本验证显示,ccRCC组织中CD44 mRNA和蛋白质表达显著增加,在4例转移性ccRCC病例中观察到强CD44染色。体外实验表明,CD44过表达促进细胞增殖、迁移和侵袭。体内实验也证明,CD44过表达加速小鼠肿瘤形成。最后,我们发现CD44调节ccRCC中HAS1的表达,这对MMP9的分泌和细胞迁移能力至关重要。
ccRCC中CD44 mRNA和蛋白质表达上调表明临床预后不良。据信CD44/HAS1/MMP9轴对ECM降解和ccRCC转移的调节有显著影响。